Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Cancer Clin Oncol ; 25(2): 263-9, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2702981

ABSTRACT

Advanced subcutaneous Colon 38 tumours in mice were used for the assessment of activity of a number of anticancer drugs. Activity was measured by histological examination of tumours 24 h after a single dose of the drug and in some cases by tumour growth delay. Agents thought to exert their cytotoxic effect by damaging DNA, including Adriamycin, amsacrine and its analogue CI-921, cyclophosphamide, 5-fluorouracil and methotrexate produced no gross histological changes after 24 h, even though some delayed the growth of subcutaneous tumours. In contrast, flavone acetic acid, fostriecin and homoharringtonine caused extensive necrosis of tumours after 24 h, and each delayed the growth of advanced subcutaneous tumours by at least 10 days when administered as a single dose. The histological effects of flavone acetic acid and fostriecin were indistinguishable from those of recombinant human tumour necrosis factor alpha. It is proposed that histological assay of advanced tumours may provide a useful adjunct to existing methods in screening for antitumour agents with novel mechanisms of action.


Subject(s)
Alkaloids/therapeutic use , Antineoplastic Agents/therapeutic use , Colonic Neoplasms/drug therapy , Flavonoids/therapeutic use , Harringtonines/therapeutic use , Tumor Necrosis Factor-alpha/therapeutic use , Alkenes/therapeutic use , Animals , Antibiotics, Antineoplastic/therapeutic use , Colonic Neoplasms/pathology , Drug Screening Assays, Antitumor , Homoharringtonine , Mice , Mice, Inbred Strains , Polyenes , Pyrones
SELECTION OF CITATIONS
SEARCH DETAIL
...